undamentalytics Newsletter
Sign in

Inovio Pharmaceuticals, Inc. revenue

Inovio Pharmaceuticals, Inc.'s revenue was $65,343 in fiscal 2025, down 70.0% on the year before. Since fiscal 2009 ($9.1m) it has grown at a compound -26.6% a year. Over the last twelve months it was $0.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue96104131041354230472101000
Growth on the year before—−32.6%+59.4%−58.0%+227.0%−22.4%+288.0%−12.8%+19.4%−27.8%−86.5%+80.2%−76.1%+478.2%−91.9%−73.8%−70.0%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Inovio Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Inovio Pharmaceuticals, Inc.